Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
Teva Pharmaceutical Industries Ltd. - Pioneering partnerships were a hot topic at the #EastWestCEO conference in San Francisco, where Teva's Head of Corporate Business Development, Ivana Magovcevic-Liebisch, moderated a discussion with J&J
![Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/979/66979/slides/1.jpg?1614966828)
Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha
![Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates, Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,](https://c8.alamy.com/comp/2CX4Y3N/teva-pharmaceutical-industries-new-ceo-jeremy-levin-speaks-during-a-news-conference-in-tel-aviv-may-9-2012-teva-pharmaceutical-industries-posted-a-40-percent-jump-in-quarterly-profit-that-beat-estimates-boosted-by-robust-sales-of-its-own-branded-products-and-generic-medicines-in-the-united-states-reutersnir-elias-israel-tags-business-health-2CX4Y3N.jpg)
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
![Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly](https://c8.alamy.com/comp/2D1NC3K/shlomo-yanai-tevas-president-and-chief-executive-speaks-to-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-headshot-2D1NC3K.jpg)
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
![TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design](https://i.pinimg.com/736x/fa/d7/e9/fad7e9d456fb75d4dc1a2540bcb9af95--auckland-exhibition.jpg)
TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design
![Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com](https://www.jewishpress.com/wp-content/uploads/2022/07/Teva-Pharmaceutical-Industries-CEO-Kare-Schultz-speaks-at-a-press-conference-at-the-Tel-Aviv-Stock-Exchange-February-19-2020..jpg)